Back to results
CompletedPhase 2

Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease

NCT01683292

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Southern General Hospital

Glasgow, United Kingdom

View on ClinicalTrials.gov
Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease — TrialFind